“…Previous studies have shown that single-dose VarV performed satisfactorily in China, with vaccine effectiveness (VE) between 50.3% and 83.9% (Fu et al, 2010;Pan et al, 2018;Wang et al, 2013). However, in some cities with high economic productivity in China, such as Beijing and Shanghai, school outbreaks continue to occur despite high VarV coverage (Fu et al, 2015;Lu et al, 2012;Suo et al, 2017;Zhu et al, 2017). To contain varicella outbreaks, the administration of VarV has been recommended as a post-exposure prophylaxis (PEP) strategy in Chinese metropolitan cities, including Beijing (2006), Guangzhou (2012), and Shanghai (2013) (Cao et al, 2018;Li, 2013;Ma et al, 2009).…”